Skip to main content

Table 2 Thymosin β levels and frequency detection in different subgroups

From: Thymosin β4 and β10 in Sjögren’s syndrome: saliva proteomics and minor salivary glands expression

 

4

10

4 sulfoxide

pSS

3.5 ± 3.1 (n = 8)a

0.2 ± 0.3 (n = 6)

1.6 ± 3.3 (n = 4)a

ss/SSc

0.7 ± 1.0 (n = 6)b

0.03 ± 0.05 (n = 3)a,b

0.2 ± 0.4 (n = 3)

ss/SLE

0.6 ± 0.4 (n = 7)b

N/A (n = 1)

N/A (n = 1)

ss/RA

1.2 ± 1.1 (n = 6)

N/A (n = 1)

N/A (n = 1)

SSc

0.3 ± 0.6 (n = 3)b

N/A (n = 0)b

N/A (n = 0)

SLE

0.1 ± 0.2 (n = 2)a,b

N/A (n = 0)b

N/A (n = 0)

RA

0.2 ± 0.4 (n = 3)

N/A (n = 0)b

N/A (n = 0)

HC

0.8 ± 0.6 (n = 9)

N/A (n = 0)b

N/A (n = 0)

  1. Abbreviations: pSS Primary Sjögren’s syndrome, ss Sicca syndrome, SSc Systemic sclerosis, SLE Systemic lupus erythematosus, RA Rheumatoid arthritis, HC Healthy control subjects, N/A Not applicable to the comparison between levels (as continuous variable) because of too few patients with detectable thymosins in the considered group
  2. Values are the mean ± SD protein levels in the extracted ion current area (×108). Values in parentheses are the number of subjects in whom the protein was identified
  3. a p ≤ 0.05 vs HC either in levels of thymosin β and/or in its presence
  4. b p ≤ 0.05 vs pSS either in thymosin β levels and/or in its presence